Aktie 853681 AJINOMOTO CO., INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Ajinomoto Co., Inc.

Aktien

853681

JP3119600009

2802

Verzögert Japan Exchange
Andere Börsenplätze
 08:00:00 26.04.2024 		% 5 Tage % 1. Jan.
5 775 JPY +1,57 % Intraday Chart für Ajinomoto Co., Inc. +7,50 % +6,16 %
27.03. Transcript : Ajinomoto Co., Inc. - Analyst/Investor Day
26.03. Ajinomoto Co, Inc. Verbessert StemFit iPS Zell-Expansionsmedium CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Ajinomoto : Enhancing Corporate Value through ASV Management
Ajinomoto : Sustainability Initiatives Aimed at Enhancement of Corporate Value
TechMagic, Inc. announced that it has received funding from a group of investors
Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium
Ajinomoto (Malaysia) Closes MYR408 Million Sale of Six Kuala Lumpur Land Plots
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on November 13, 2023.
Ajinomoto Co., Inc.'s Equity Buyback announced on November 13, 2023, has closed with 7,003,300 shares, representing 1.35% for ¥39,999.85 million.
Tsubame BHB Co., Ltd. announced that it has received ¥5.3 billion in funding from a group of investors
Ajinomoto Foods Restates Commitment to Quality Products
Inglewood Co., Ltd. announced that it has received funding from Ajinomoto Co., Inc.
Ribomic and Ajinomoto Co. Partner for Nucleic Acid Aptamer Research
Ribomic Enters Into Drug Research Collaboration with Ajinomoto
RIBOMIC Inc. and Ajinomoto Co., Inc. Announce Joint Research Agreement
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on November 13, 2023.
New acquisition to support global gene therapy manufacturing
Forge Biologics - Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1
Japan's Ajinomoto to buy US-based Forge Biologics for $546 million
Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1
Ajinomoto Co., Inc. announces an Equity Buyback for 10,000,000 shares, representing 1.92% for ¥40,000 million.
Ajinomoto Co., Inc. authorizes a Buyback Plan.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 853681 Aktie
  4. Nachrichten Ajinomoto Co., Inc.
  5. Andere Sprachen